The American Heart Association (AHA) and the Patient-Centered Outcomes Research Institute (PCORI) recently said they have developed a new Researcher and Clinician Challenge to improve care for cardiovascular diseases.
Officials with the U.S. Food and Drug Administration recently granted marketing approval for two Trevo clot retrieval devices to treat strokes because of blood clots (ischemic) and to decrease speech difficulties, paralysis and similar stroke disabilities.
Leaders with the U.S. Food and Drug Administration (FDA) recently released a revised guidance recommendation, encouraging universal testing for Zika virus in all whole blood as well as blood components within the U.S. and its territories.
GlaxoSmithKline (GSK) plans to present updates about emerging studies from the company’s comprehensive respiratory portfolio of investigational programs, approved medicines and scientific collaborations.
A recent study suggests that a commonly used diabetes drug could inhibit the weight gain that children and teens with autism typically experience when they take two medicines that are designed to decrease their agitation.
A team of researchers at the National Center for Advancing Translational Sciences (NCATS), a branch of the National Institutes of Health (NIH), recently discovered compounds that may be useful for stopping the Zika virus.
The American Heart Association (AHA) 'Rapid Access Journal Report' recently stated that researchers have discovered a connection between late-onset asthma and an increased risk of heart disease and stroke.
The National Institutes of Health’s National Institute on Minority Health and Health Disparities (NIMHD) recently established the Transdisciplinary Collaborative Centers (TCC) for Health Disparities Research on Chronic Disease Prevention.
The American Cancer Society recently published 'Breast Cancer Clear & Simple, Second Edition: All Your Questions Answered' to give newly diagnosed breast cancer patients more hope and information about their health.